TG Therapeutics, Inc. is a biopharmaceutical company focusing on innovative treatments for B-cell mediated diseases. Their products include BRIUMVI for multiple sclerosis and Umbralisib for lymphoma. The company also has various investigational medicines in its research pipeline.